A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque.
about
The structure of AAVrh32.33, a novel gene delivery vectorProgress and prospects: immune responses to viral vectorsHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsRefining the approach to vaccines against influenza A viruses with pandemic potential.Viral vector-based influenza vaccines.AAV provides an alternative for gene therapy of the peripheral sensory nervous system.Virus-vectored influenza virus vaccines.A Novel Adeno-Associated Virus-Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine.Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of CancerIntranasal vaccination with AAV5 and 9 vectors against human papillomavirus type 16 in rhesus macaquesOral vaccination with adeno-associated virus vectors expressing the Neu oncogene inhibits the growth of murine breast cancer.Bioengineering of AAV2 capsid at specific serine, threonine, or lysine residues improves its transduction efficiency in vitro and in vivo.AAV Vectors Vaccines Against Infectious Diseases.Virus expression vectors.Developments in Viral Vector-Based Vaccines.Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.Incorporation of antigens into viral capsids augments immunogenicity of adeno-associated virus vector-based vaccines.Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing.An alternate route for adeno-associated virus entry independent of AAVR.Bioengineered Viral Platform for Intramuscular Passive Vaccine Delivery to Human Skeletal MuscleEngineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
P2860
Q27682946-2FFD18D0-B524-4A05-80AF-EB586FBC2BA7Q28264531-008C2EDF-FA13-470E-BE81-5904D6075600Q28394899-2C03541F-E03A-49C6-9663-5494608D32BAQ30381595-12EEFC09-2213-4A0C-A47F-76D22A828A40Q30390938-8024A81E-C67D-4954-97D4-8257FB4514ABQ33822179-B152DA54-BF99-4260-A840-BF9FBF545844Q34102268-02C6D27F-EE59-4BE3-BB68-EEF7E0CD708AQ35837765-16747EF7-ABFE-4E0F-96A9-EC0529DD86C9Q35949356-89B5F7E9-4856-4739-88C8-BFA19FF36F23Q36114234-B0D30959-3BF5-439E-BBDC-B602F5E8BB9AQ36659250-95F48FDE-B314-4C56-BF34-02183236A5CBQ37066323-5020E97A-B8DE-478E-A91C-A8650F472204Q37498000-9167FCEF-2D56-44D8-9643-206EB42F643EQ38226671-9BD9BEE0-96F3-445C-AA92-9FD97026FB45Q38582090-F47C3C11-7B7F-4C55-9F81-9363E1D8048AQ39240212-DE3168A6-00EB-4CC4-8DAC-1F81E62F59A7Q41644107-A6415159-6CEC-42C9-BCDC-21F943F8843BQ42408255-B76D24B1-4691-4827-AD7B-73BEA18B535CQ47552291-BABD03F0-A19E-4275-ACF4-242F140AC9B1Q56889545-690B4161-6FFA-4077-9569-355CDEBA8121Q57059896-A3345ECE-2B75-471A-85A4-966FF4DF4392
P2860
A new genetic vaccine platform based on an adeno-associated virus isolated from a rhesus macaque.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A new genetic vaccine platform ...... solated from a rhesus macaque.
@en
A new genetic vaccine platform ...... solated from a rhesus macaque.
@nl
type
label
A new genetic vaccine platform ...... solated from a rhesus macaque.
@en
A new genetic vaccine platform ...... solated from a rhesus macaque.
@nl
prefLabel
A new genetic vaccine platform ...... solated from a rhesus macaque.
@en
A new genetic vaccine platform ...... solated from a rhesus macaque.
@nl
P2093
P2860
P356
P1433
P1476
A new genetic vaccine platform ...... solated from a rhesus macaque.
@en
P2093
James M Wilson
Jianping Lin
Luk H Vandenberghe
Peter Bell
Roberto Calcedo
Suryanarayan Somanathan
P2860
P304
12738-12750
P356
10.1128/JVI.01441-09
P407
P577
2009-10-07T00:00:00Z